Client News

Atriva Therapeutics Announces Changes to Advisory Board

XPHYTO announces business strategy and milestones for 2021: Innovation to impact

ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy

AiCuris selects three novel anti-infective treatment approaches as winners of the AiCubator Resident Status, a corporate innovative accelerator initiative

Adocia Files Patent on a Hydrogel Scaffold for Cell Therapy in the Treatment of Type 1 Diabetes

AiCuris to Present at the 39th Annual J.P. Morgan Healthcare Conference

CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA(R) in gene therapy

sterna biologicals GmbH & Co. KG raises further EUR 10.0 million (approx. USD 11.9 million) in Series A – 2nd closing private placement

RedHill Biopharma’s RHB-204 Granted FDA Fast Track Designation for NTM Disease

Atriva Therapeutics obtains approval from German authorities for Phase II trial in COVID-19 patients, led by Charité Clinic in Berlin